- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04070144
The First Puncture Success Rate of a Novel Injeq IQ-Tip™ System in Pediatric Lumbar Punctures (IQ-LP-03)
Study Overview
Detailed Description
The primary purpose of the investigation is to demonstrate the claimed clinical benefit and safety of Injeq IQ-Tip™ system.
IQ-Tip™ is similar to common spinal needles with a custom-made stylet that enables the real-time bioimpedance measurement at the tip of the needle. The needle is connected to the analyzer device, which provides real-time CSF detection during lumbar puncture from the very tip of the needle and by these means assists conducting the medical procedure.
The investigation aims to demonstrate the first puncture success rate, as proxy of clinical benefit and clinical performance, of bioimpedance spectroscopy based spinal needle guidance method among pediatric hemato-oncology patients requiring lumbar punctures.
The investigation is conducted in the pediatric hematology and oncology units of three Finnish university hospitals
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Helsinki, Finland
- Helsinki University Hospital, New Children's Hospital
-
Tampere, Finland
- Tampere University Hospital
-
Turku, Finland
- Turku University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pediatric hemato-oncology patients whose diagnosis or treatment plan requires lumbar puncture to acquire a CSF sample or to inject drug or other substance
- Written and signed informed consent before the procedure from the parent and/or patient depending on the age of the patient
Exclusion Criteria:
- Parents and/or patient refusal to participate or parents and/or patient unable to give informed consent
- Any contraindications to a lumbar puncture. Contraindications include skin infection around the puncture area, unstable hemodynamics, bleeding tendency and increased intracranial pressure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: IQ-Tip
At most four lumbar punctures with Injeq IQ-Tip(tm) system per participant
|
Physician performs therapeutic or diagnostic lumbar puncture using Injeq IQ-Tip(tm) system
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The First Puncture Success Rate
Time Frame: The assessment immediately following each lumbar puncture procedure
|
Each individual lumbar puncture procedure is assessed as either 'first puncture success' or '-failure'. Success rate = Successes / All procedures Definition of the first puncture success:
|
The assessment immediately following each lumbar puncture procedure
|
|
Rate of Serious Adverse Events
Time Frame: The assessment during four-week follow-up after each lumbar puncture procedure
|
Total number of serious adverse events caused by the device.
Serious adverse event in probable or causal relationship to the investigational device exposure
|
The assessment during four-week follow-up after each lumbar puncture procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Procedures With Post-dural Puncture Headache (PDPH)
Time Frame: The assessment during 7-day follow-up after each lumbar puncture procedure
|
PDPH defined as headache that:
Possible symptoms are recording using a diary filled by the patient or parents and verified by the study nurse. |
The assessment during 7-day follow-up after each lumbar puncture procedure
|
|
Percentage of CSF Samples With Greater or Equal to 10 Erythrocytes / mm^3
Time Frame: The laboratory analysis within 3 hours of the lumbar puncture
|
Erythrocyte (red blood cell) count according to laboratory analysis in units of 10^6/liter or 1/mm3
|
The laboratory analysis within 3 hours of the lumbar puncture
|
|
Percentage of Procedures With Other Complications or Adverse Events
Time Frame: The assessment during 7-day and four-week follow ups
|
E.g. PDPH or backache Possible symptoms are recorded using a diary filled by the patient or parents and verified by the study nurse. Diary is an open questionaire that is intended for recording any possible complication. Possible complications are not considered as pre-determined outcome measures, with the exception of Outcome #3 (rate of PDPH) Four-week follow up conducted by the study nurse from the hospital registers |
The assessment during 7-day and four-week follow ups
|
|
Aggregate Sensitivity of CSF Detection
Time Frame: The assessment immediately following each lumbar puncture procedure
|
The CSF detection performance of the investigational device is assessed by the physician. Each individual lumbar puncture procedure is classified as either 'True Positive CSF detection (TP)', 'False Negative CSF detection (FN)' or 'Procedure failed (Fail)' by the investigator. The aggregate sensitivity = Number of TPs / Total number of procedures |
The assessment immediately following each lumbar puncture procedure
|
|
Aggregate False Detection Rate of CSF Detection
Time Frame: The assessment immediately following each lumbar puncture procedure
|
Each individual lumbar puncture procedure is classified as either 'One or more False Positive CSF detections (FP)' or 'No False Positive CSF detections (TN)'. The aggregate false detection rate = Number of FPs / Total number of procedures |
The assessment immediately following each lumbar puncture procedure
|
|
Number of Required Attempts Per Successful Lumbar Puncture Procedure
Time Frame: The assessment immediately following each lumbar puncture procedure
|
In line with definition of 'the first puncture success rate', attempt is defined as: any new penetration of skin is considered a new attempt. Lumbar puncture is considered successful irrespective of the number of punctures if the CSF sample was eventually obtained and/or the injection of medicine could be performed |
The assessment immediately following each lumbar puncture procedure
|
|
Number of Failed Lumbar Puncture Procedures
Time Frame: The assessment immediately following each lumbar puncture procedure
|
Procedure is considered failed if physicians, even after multiple attempts, conclude that the lumbar puncture cannot be completed with available personnel or equipment due to any reason
|
The assessment immediately following each lumbar puncture procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sauli Palmu, PhD MD, Tampere University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IQ-LP-03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Puncture
-
Dartmouth-Hitchcock Medical CenterTerminated
-
Thomas Jefferson UniversityMayo ClinicCompleted
-
Boston Children's HospitalCompletedTraumatic Lumbar PunctureUnited States
-
University Hospital, Strasbourg, FranceCompleted
-
Seattle Children's HospitalLife Sciences Development FundUnknown
-
University of Alabama at BirminghamCompletedPediatric Lumbar PunctureUnited States
-
Columbia UniversityCompletedInfant Lumbar PunctureUnited States
-
Children's Hospital of PhiladelphiaActive, not recruiting
-
Injeq LtdCompletedPediatric Lumbar PunctureFinland
-
University of NebraskaUnknownIndication for Lumbar PunctureUnited States
Clinical Trials on IQ-Tip(tm) system
-
Tandem Diabetes Care, Inc.RecruitingDiabetes Mellitus, Type 1France
-
Zimmer BiometActive, not recruitingOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Revision Total Shoulder Arthroplasty | Ununited Humeral Head Fracture | Irreducible 3-and 4-part Proximal Humeral Fractures | Gross Rotator Cuff DeficiencyUnited States, United Kingdom
-
Sun Yat-sen UniversityRecruitingPeripherally Inserted Central CathetersChina
-
Northwestern UniversityRecruitingEvaluate Patient Comfort Level During Paracentesis by Numbing Skin With a Needle-less Device, Instead of Using a Needle to Numb the SkinUnited States
-
CSA Medical, Inc.TerminatedCancer | Pleural NeoplasmsUnited States
-
MetaCure (USA), Inc.TerminatedOverweight | Type 2 Diabetes MellitusUnited States
-
Ethicon, Inc.CompletedConservative Gynecological ProceduresUnited States
-
Abbott Medical DevicesGuidant CorporationCompletedAtherosclerotic Disease, CarotidUnited States
-
3MCompletedTemperature | Body Temperature | ThermosensingUnited States